Purchase Order 75N90024P00372
Award Date 5/15/24
Potential Completion Date 8/30/24
Potential Value $39K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Franklin Lakes, NJ 07417, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Clinical Center. Valued at eleven thousand six hundred seventy-one dollars and sixty cents ($11,671.60), this award is for the RHAPSODY Targeted mRNA ABSEQ Kit. Delivery is required by February 23, 2024. As a manufacturer and supplier of medical devices, instruments, reagents, and related products, BD will provide the requested...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,072.00 firm fixed price purchase order contract to Becton, Dickinson And Company (BD) for BD reagents to support vaccine research. The contract does not have a set-aside designation and is scheduled for completion on February 24, 2023. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and...
- This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Becton, Dickinson and Company (BD) for the supply of D RHAPSODY SINGLE-CELL ANALYSIS REAGENT KITS. The contract has a ceiling value of $16,130.00 and a completion date of October 9, 2025. The contract is not designated as a set-aside. BD is a global medical technology company that provides a range of medical devices, diagnostic products, and laboratory equipment to federal...
- Becton, Dickinson and Company (BD), through its BD Biosciences division, has been awarded a Purchase Order valued at $23,491.28 by the National Institutes of Health (NIH) Clinical Center for the procurement of BD Rhapsody Single-Cell Analysis Reagent Kits. This firm fixed-price contract, awarded on September 26, 2025, represents a child award under BD's parent entity and will be performed in San Jose, California, with an ultimate completion date of September 25, 2026. No small business set-aside...
- The National Institutes of Health (NIH) Clinical Center awarded a firm-fixed price purchase order to Becton, Dickinson and Company (BD) for $85,000 to procure various types of reagents and supplies for the Microbiology Service's clinical testing. This was a sole-source award as BD is the only vendor that can provide the required test menu and instrumentation-compatible products. The contract has a base period of 12 months from the award date of April 24, 2020. BD, a large manufacturer of medical...
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Becton, Dickinson & Co (BD), a global medical technology company. The $23,686.25 firm fixed-price purchase order is for the supply of Rhapsody Targeted mRNA AbSeq Kits and AB-O Single Cell Sample Multiplexing Kits. The contract has a period of performance through July 19, 2025 and was awarded on a full and open competition basis without any set-aside designation. BD is an established...
- This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) to Becton, Dickinson and Company (BD) on September 29, 2016. The contract has a ceiling value of $629,198.12 and a period of performance through December 31, 2018. BD, a global medical technology company, is providing the NIH Clinical Center with a range of goods and services through this contract, including instruments, reagents, and associated maintenance and services to support biomedical...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $33,675.60. The contract is for BD Biosciences, a division of BD, to provide biomedical instruments, reagents, and services that support flow cytometry, cell imaging, and genomics technologies. BD has extensive experience providing specialized equipment and consumables to support...
- Becton, Dickinson and Company, operating through its BD Diagnostic Systems division, was awarded a $170,000 firm-fixed-price purchase order contract by the Department of Health and Human Services National Institutes of Health Clinical Center. The contract is for the supply of various reagents, blood culture, and MGIT testing products to support the detection of pathogens that cause infections in NIH patients. The contract has a base year from April 2021 to April 2022, with one option year to...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health Clinical Center to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, reagents, and related products. The contract has a potential value of $150,000.00 and a completion date of December 31, 2019. The contract does not have a set-aside designation. BD has received numerous federal contract awards, including with the Department...